Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under the Food and Drug Administration’s Emergency Use Authorization in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. On August 23, 2021, it was granted full approval by the FDA.